Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Gilead Sciences, Inc
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
A Phase 2 clinical trial investigating the anti-virus effects, kinetics and safety of GS-5806 in adults with RSV (Respiratory Syncytial Virus) infection
The primary objective of this study is to evaluate the effects of presatovir (GS-5806) on RSV viral load in RSV-positive adults hospitalized with acute respiratory infectious symptoms.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
A study to investigate a new drug to treat Type 2 Diabetes
The primary objective of the study is to: • Determine the effect of ranolazine on hemoglobin A1c (HbA1c) after 24 weeks of treatment when added to glimepiride in subjects who have inadequately cont...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
A Study of Bone Mineral Density in HIV Infected Subjects Estudio de Densidad Mineral Ósea en sujetos infectados por VIH
To characterize the profile of low bone mineral density (BMD) in ? 50 year old male subjects and post-menopausal female subjects on any tenofovir disoproxil fumarate (TDF)-based regimen relative to th...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
An investigational study to assess the effect of GS-5745 on adult patients with Cystic Fibrosis. Estudio para evaluar el efecto de GS-5745 en pacientes adultos con Fibrosis Quistica
To evaluate the effect of GS-5745 on pre-bronchodilator forced expiratory volume in 1 second (FEV1) in subjects with cystic fibrosis (CF) after 8 weeks of treatment Evaluar el efecto de GS-5745 ...
Country
None
organs
None
Specialty
None
unknown
More information
Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
A study to compare the safety and effectiveness of F/TAF vs F/TDF (Truvada) once daily for the prevention of HIV, in men and transgender women who have sex with men and are at risk of HIV infection
The primary objective of this study is: - To assess the rates of HIV-1 seroconversion in men (MSM) and transgender women (TGW) who have sex with men who are administered daily F/TAF or F/TDF with a m...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
Clinical Trial to Assess the Safety and Efficacy of Aztreonam for Inhalation Solution (AZLI) in patients with Cystic Fibrosis (CF) and Chronic Burkholderia Species Infection
The primary objective is to evaluate the safety and efficacy of continuous AZLI treatment in subjects with CF and Burkholderia spp. infection in the airways.
Country
None
organs
None
Specialty
None
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
A study to evaluate if a new drug is effective in preventing the progression of lung fibrosis
The primary objective of this study is: To determine the effect of GS-6624 on progression free survival (PFS) as determined by either a categorical decline in forced vital capacity (FVC) and all cau...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
An investigational study to assess the safety and efficacy of a new investigational drug in subjects with primary sclerosing cholangitis (PSC)
To evaluate whether GS-6624 is effective at preventing the progression of liver fibrosis in subjects with PSC.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
A study to provide access to idelalisib in combination with rituximab for the treatment of previously treated chronic lymphocytic leukemia
To provide idelalisib in an open-label format prior to the expected time of regulatory approval to subjects with relapsed CLL who have limited treatment options.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Gilead Sciences, Inc
Update Il y a 5 ans
ARTEMIS-PH: A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of Ambrisentan in Subjects with Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
The primary objective of this study is to compare the change in 6-minute walk distance (6MWD) after initiating ambrisentan or placebo treatment in subjects with pulmonary hypertension (PH) associated ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
1
2
3
4
5
6
7
8
9
10
Next